Hi, Gang,
Back intact from another stellar climbing trip. Great weather, good company, good routes . . . and the hardest onsight of my climbing career (11+, for those that understand these things). Can't think of a bad thing to say about the trip. And I'm not oozing any plasma for a change! I'm road weary, but more ready to sit in my chair and do stock stuff now.
Anyhow, I see a couple of things have transpired in the world of BLUE H in my absence. PBSC munched for no premium; what's up with that? It's a good fit for PKI, IMO, but why so cheap? I also see that CURN hit my sell target of $2.40, and CIPH hit my buy target of $4.90.
I was hoping for more comment on CIPH than a mention of price action, but I'm used to such disappointments. Actually, y'all have been good about this, in general, so I won't whine further. I'll just buy it and see what y'all do then.
MCLS warned, beating it back below $2. I have to give myself a pat on the back for not just the buy, which I'm fairly good at, but also the sell, which I'm not. Guess I'm finally catching on. It may be a while before it has another run like it did last month, but I do like it as an intermediate term buy under $2. BLUE H will likely start accumulating again, first by buying another 500 shares about now, and then by watching for elephants again. As mentioned in the subject post, "best to swing or position trade these babies."
More tomorrow when I'm not so tired.
Cheers, Tuck |
